CG
BIIB icon

Clinton Group’s Biogen BIIB Stock Holding History

Clinton Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,553
Closed -$495K – 368
2017
Q4 		$495K Buy
1,553
+602
+63% +$193K 0.04% 319
2017
Q3 		$298K Sell
951
-1,432
-60% -$424K 0.03% 329
2017
Q2 		$647K Sell
2,383
-1,150
-33% -$304K 0.07% 333
2017
Q1 		$966K Sell
3,533
-16,382
-82% -$4.63M 0.06% 436
2016
Q4 		$5.65M Buy
+19,915
New +$5.9M 0.33% 84
2016
Q1 		– Sell
-2,230
Closed -$683K – 863
2015
Q4 		$683K Buy
+2,230
New +$641K 0.06% 444
2015
Q2 		– Sell
-1,497
Closed -$632K – 583
2015
Q1 		$632K Sell
1,497
-346
-19% -$136K 0.16% 198
2014
Q4 		$626K Buy
1,843
+368
+25% +$119K 0.2% 174
2014
Q3 		$488K Sell
1,475
-471
-24% -$155K 0.2% 166
2014
Q2 		$614K Buy
1,946
+794
+69% +$239K 0.31% 88
2014
Q1 		$352K Sell
1,152
-2,415
-68% -$767K 0.13% 236
2013
Q4 		$997K Buy
+3,567
New +$923K 0.33% 45
2013
Q3 		– Sell
-1,476
Closed -$318K – 329
2013
Q2 		$318K Buy
+1,476
New +$315K 0.1% 197

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Clinton Group's BIIB Position: Q1 2018 in Review

Clinton Group sold out of Biogen (BIIB) in Q1 2018, closing a stake of 1,553 shares — an estimated $495K sold.

Clinton Group first reported a position in BIIB in Q2 2013 and held it in 13 quarters. The position peaked at $5.65M in Q4 2016. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Clinton Group reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Clinton Group sold 1,553 Biogen shares in Q1 2018, an estimated $495K.
  • Clinton Group first reported a position in Biogen in Q2 2013 and held it in 13 quarters.
  • Clinton Group's Biogen position peaked at $5.65M in Q4 2016.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Clinton Group's 13F filing for Q1 2018, filed 14 May 2018.